AnalystsJeffrey La RosaJeffrey La Rosa's Stock Forecasts
AnalystsJeffrey La Rosa
Sectors:
Industries:
Analyst Ranking
Bottom 12%
#4945 out of 5550 analysts
Average Return
-47.84%
Win Rate
17%1 out of 6
Risk vs Reward
Poor
Good
Jeffrey La Rosa's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merck & Co IncMRK | +2.03% | $100.77 | $102.82 | 2022-10-28 - 2023-10-27 | Buy |
Jeffrey La Rosa Analyst Color
Get additional color on Jeffrey La Rosa's coverage of popular stocks
Jeffrey La Rosa's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pyxis Oncology IncPYXS | 2 | Buy | $7.00 | +286.74% | Maintains | 4 months ago |
Senti Biosciences Holdings IncSNTI | 1 | Buy | $6.00 | +3,536.36% | Initiates Coverage On | a year ago |
Janux Therapeutics IncJANX | 2 | Buy | $91.00 | N/A | Maintains | 2 years ago |
Merck & Co IncMRK | 1 | Buy | $112.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.